Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alaa M Mostafa

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Clinical and Experimental Medicine|December 25, 2025
MAFLD increases CKM syndrome severity: a NHANES-based cross-sectional studyAlaa M Mostafa, Yasser Fouad, Ziayn Pan, et al.
Clinical and Experimental Hepatology|April 28, 2025
Prevalence and risk factors of liver fibrosis in patients with metabolic-associated fatty liver disease undergoing bariatric surgeryAmr Elsayed, Alshymaa Hassnine, Mariana F Gayyed, et al.
Scientific Reports|August 24, 2025
HOMA-IR, an independent predictor of advanced liver fibrosis in metabolic-dysfunction associated fatty liver disease: a cross-sectional study in Egyptian patientsYasser Fouad, Ziyan Pan, Shaymaa Nafady, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|May 8, 2025
Evaluation of Stigma Toward Fatty Liver DiseaseYasser Fouad, Alaa M Mostafa, Ziyan Pan, et al.
BMC Gastroenterology|March 14, 2026
Dietary recommendations for patients with chronic liver diseases: the need for increased awareness among non-hepatologist physiciansYasser Fouad, Alaa M Mostafa, Safaa M Abdelhalim, et al.
BMC Gastroenterology|March 20, 2026
Association between serum uric acid and non-alcoholic fatty liver disease (NAFLD): an observational cross-sectional study in an Egyptian outpatient cohortHaitham A Mahmoud, W Mohamed Abd Elghany, Mohammed Abdelhakeem, et al.
Annals of Hepatology|January 11, 2026
The African Middle East Association of Gastroenterology (AMAGE) clinical practice guidelines for the diagnosis and management of metabolic dysfunction associated fatty liver diseaseYasser Fouad, Reda Elwakil, Faisal M Sanai, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Clinical and Experimental Medicine|December 25, 2025
MAFLD increases CKM syndrome severity: a NHANES-based cross-sectional studyAlaa M Mostafa, Yasser Fouad, Ziayn Pan, et al.
Clinical and Experimental Hepatology|April 28, 2025
Prevalence and risk factors of liver fibrosis in patients with metabolic-associated fatty liver disease undergoing bariatric surgeryAmr Elsayed, Alshymaa Hassnine, Mariana F Gayyed, et al.
Scientific Reports|August 24, 2025
HOMA-IR, an independent predictor of advanced liver fibrosis in metabolic-dysfunction associated fatty liver disease: a cross-sectional study in Egyptian patientsYasser Fouad, Ziyan Pan, Shaymaa Nafady, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|May 8, 2025
Evaluation of Stigma Toward Fatty Liver DiseaseYasser Fouad, Alaa M Mostafa, Ziyan Pan, et al.
BMC Gastroenterology|March 14, 2026
Dietary recommendations for patients with chronic liver diseases: the need for increased awareness among non-hepatologist physiciansYasser Fouad, Alaa M Mostafa, Safaa M Abdelhalim, et al.
BMC Gastroenterology|March 20, 2026
Association between serum uric acid and non-alcoholic fatty liver disease (NAFLD): an observational cross-sectional study in an Egyptian outpatient cohortHaitham A Mahmoud, W Mohamed Abd Elghany, Mohammed Abdelhakeem, et al.
Annals of Hepatology|January 11, 2026
The African Middle East Association of Gastroenterology (AMAGE) clinical practice guidelines for the diagnosis and management of metabolic dysfunction associated fatty liver diseaseYasser Fouad, Reda Elwakil, Faisal M Sanai, et al.
Pageof 2